Tatjana Stanković

9.6k total citations · 2 hit papers
91 papers, 6.1k citations indexed

About

Tatjana Stanković is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Tatjana Stanković has authored 91 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 47 papers in Genetics and 34 papers in Oncology. Recurrent topics in Tatjana Stanković's work include Chronic Lymphocytic Leukemia Research (47 papers), DNA Repair Mechanisms (31 papers) and Cancer-related Molecular Pathways (26 papers). Tatjana Stanković is often cited by papers focused on Chronic Lymphocytic Leukemia Research (47 papers), DNA Repair Mechanisms (31 papers) and Cancer-related Molecular Pathways (26 papers). Tatjana Stanković collaborates with scholars based in United Kingdom, United States and Germany. Tatjana Stanković's co-authors include A. Malcolm R. Taylor, Grant S. Stewart, Paul Moss, Philip J. Byrd, P.J. Byrd, Ceri Oldreive, Anja Raams, Debra A. Bressan, Richard S. Maser and Mark I. Kaplan and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Tatjana Stanković

91 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The DNA Double-Strand Break Repair Gene hMRE11 Is Mutated in Individuals with an Ataxia-Telangiectasia-like Disorder

1999 802 citations Grant S. Stewart, Tatjana Stanković et al. profile →
The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damage

2009 599 citations Grant S. Stewart, Ceri Oldreive et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tatjana Stanković United Kingdom	37	4.3k	2.3k	1.4k	1.1k	1.0k	91	6.1k
Steven I. Wang United States	7	5.6k 1.3×	1.5k 0.6×	788 0.5×	1.1k 1.1×	1.2k 1.2×	8	6.9k
Janusz Puc United States	11	4.7k 1.1×	1.4k 0.6×	671 0.5×	749 0.7×	1.0k 1.0×	21	5.7k
Sı́lvia Beà Spain	40	1.9k 0.5×	1.9k 0.8×	1.6k 1.1×	2.8k 2.7×	694 0.7×	97	4.8k
Max Chaffanet France	36	2.4k 0.6×	1.5k 0.6×	756 0.5×	382 0.4×	1.0k 1.0×	105	4.4k
Danny Liaw United States	9	4.5k 1.1×	1.2k 0.5×	653 0.5×	884 0.8×	989 1.0×	16	5.8k
Marta Chesi United States	40	5.2k 1.2×	2.2k 1.0×	817 0.6×	654 0.6×	639 0.6×	119	7.2k
Daniel Mertens Germany	33	2.1k 0.5×	711 0.3×	1.6k 1.1×	996 0.9×	698 0.7×	93	3.8k
Grant S. Stewart United Kingdom	37	5.3k 1.2×	2.3k 1.0×	536 0.4×	497 0.5×	1.0k 1.0×	87	6.2k
Craig H. Bassing United States	45	5.5k 1.3×	2.2k 1.0×	439 0.3×	324 0.3×	1.0k 1.0×	119	7.8k
Sauveur-Michel Maira Switzerland	31	3.5k 0.8×	1.4k 0.6×	518 0.4×	506 0.5×	778 0.8×	42	4.7k

Countries citing papers authored by Tatjana Stanković

Since Specialization

Citations

This map shows the geographic impact of Tatjana Stanković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatjana Stanković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatjana Stanković more than expected).

Fields of papers citing papers by Tatjana Stanković

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatjana Stanković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatjana Stanković. The network helps show where Tatjana Stanković may publish in the future.

Co-authorship network of co-authors of Tatjana Stanković

This figure shows the co-authorship network connecting the top 25 collaborators of Tatjana Stanković. A scholar is included among the top collaborators of Tatjana Stanković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatjana Stanković. Tatjana Stanković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kwok, Marwan, Angelo Agathanggelou, & Tatjana Stanković. (2024). DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies. Blood. 143(21). 2123–2144. 7 indexed citations

Kwok, Marwan, Angelo Agathanggelou, Nicholas Davies, & Tatjana Stanković. (2021). Targeting the p53 Pathway in CLL: State of the Art and Future Perspectives. Cancers. 13(18). 4681–4681. 14 indexed citations

Branković, Ljiljana, et al.. (2019). Fetal chromosomal anomalies in southeast Serbia - single center cohort retrospective study. Genetika. 51(1). 157–166. 1 indexed citations

Davies, Nicholas, Marwan Kwok, Ceri Oldreive, et al.. (2017). Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts. Oncotarget. 8(27). 44749–44760. 10 indexed citations

Byrd, Philip J., Grant S. Stewart, Anna Jo Bodurtha Smith, et al.. (2016). A Hypomorphic PALB2 Allele Gives Rise to an Unusual Form of FA-N Associated with Lymphoid Tumour Development. PLoS Genetics. 12(3). e1005945–e1005945. 15 indexed citations

Parry, Helen, Tom H. Stevens, Ceri Oldreive, et al.. (2016). NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma. Oncotarget. 7(42). 68513–68526. 48 indexed citations

Mongini, Patricia K. A., Erin C. Boyle, Hyunjoo Lee, et al.. (2015). TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells. The Journal of Immunology. 195(3). 901–923. 42 indexed citations

Smith, Edward, Angelo Agathanggelou, Guy Pratt, et al.. (2015). UCHL1 Is a New Therapeutic Target in Lymphoid Malignancies, Independent of ATM and TP53 status. Blood. 126(23). 1746–1746. 1 indexed citations

Kwok, Marwan, Nicholas Davies, Angelo Agathanggelou, et al.. (2014). ATR Inhibition Exacerbates Replication Stress in TP53 or ATM Deficient CLL Cells and Enhances Sensitivity to Chemotherapy and Targeted Therapy. Blood. 124(21). 3340–3340. 1 indexed citations

10.

Stanković, Tatjana & Anna Skowrońska. (2013). The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia. Leukemia & lymphoma. 55(6). 1227–1239. 53 indexed citations

11.

Raa, Doreen te, Jitka Malčíková, Marek Mráz, et al.. (2012). Assessment of p53 Functionality in Chronic Lymphocytic Leukemia by Different Assays; An Eric-Wide Approach.. Blood. 120(21). 2872–2872. 1 indexed citations

12.

Skowrońska, Anna, Belinda Austen, Jean Powell, et al.. (2011). ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele. Haematologica. 97(1). 142–146. 26 indexed citations

13.

Gardiner, Anne, Helen Parker, Sharron Glide, et al.. (2011). A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemia. Leukemia Research. 36(3). 307–310. 9 indexed citations

14.

Stanković, Tatjana, et al.. (2008). Molecular mechanisms involved in chemoresistance in paediatric acute lymphoblastic leukaemia. Srpski arhiv za celokupno lekarstvo. 136(3-4). 187–192. 20 indexed citations

15.

Du, Likun, Deborah K. Dunn‐Walters, Krystyńa Chrzańowska, et al.. (2008). A Regulatory Role for NBS1 in Strand-Specific Mutagenesis during Somatic Hypermutation. PLoS ONE. 3(6). e2482–e2482. 12 indexed citations

16.

Baumforth, Karl R. N., Joanne R. Flavell, Gary Reynolds, et al.. (2005). Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells. Blood. 106(6). 2138–2146. 92 indexed citations

17.

Stanković, Tatjana, Victoria Weston, Carmel McConville, et al.. (2000). Clonal Diversity of Ig and T-cell Receptor Gene Rearrangements in Childhood B-Precursor Acute Lymphoblastic Leukaemia. Leukemia & lymphoma. 36(3-4). 213–224. 17 indexed citations

18.

Stanković, Tatjana, Peter Weber, Grant S. Stewart, et al.. (1999). Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. The Lancet. 353(9146). 26–29. 264 indexed citations

19.

Stanković, Tatjana, A. Kidd, Amanda Sutcliffe, et al.. (1998). ATM Mutations and Phenotypes in Ataxia-Telangiectasia Families in the British Isles: Expression of Mutant ATM and the Risk of Leukemia, Lymphoma, and Breast Cancer. The American Journal of Human Genetics. 62(2). 334–345. 281 indexed citations

20.

McConville, Carmel, et al.. (1996). Mutations associated with variant phenotypes in ataxia-telangiectasia.. PubMed. 59(2). 320–30. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact